PMID- 11149488 OWN - NLM STAT- MEDLINE DCOM- 20010301 LR - 20131121 IS - 0884-0431 (Print) IS - 0884-0431 (Linking) VI - 16 IP - 1 DP - 2001 Jan TI - The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation. PG - 39-45 AB - The human vitamin D receptor (hVDR) is a member of the nuclear receptor superfamily of transcriptional regulators. Here we show that tryptophan 286 of the hVDR is critical for ligand binding and transactivation of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] target genes. Two mutants of the hVDR were produced, W286A and W286F, in which the tryptophan was replaced with an alanine or a phenylalanine, respectively. The W286A mutant did not bind 1,25(OH)2D3, interact with steroid receptor coactivator 1 (SRC-1) in vitro, or activate transcription. Moreover, the W286A receptor did not heterodimerize in a ligand-dependent manner with the human retinoid X receptor alpha (hRXRalpha). Although the W286F receptor heterodimerized with hRXRalpha, interacted with SRC-1, and bound 1,25(OH)2D3, its capacity to transactivate was attenuated severely. Thus, tryptophan 286 of hVDR plays an important role in specific 1,25(OH)2D3 ligand interaction and subsequently in hVDR/RXR interaction, SRC-1 binding, and ligand-dependent transactivation of 1,25(OH)2D3 target genes. These results identify the first amino acid that is absolutely required for ligand binding in the VDR and further define the structure-function relationship of 1,25(OH)2D3 interaction with its receptor. FAU - Solomon, C AU - Solomon C AD - Department of Medicine, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada. FAU - Macoritto, M AU - Macoritto M FAU - Gao, X L AU - Gao XL FAU - White, J H AU - White JH FAU - Kremer, R AU - Kremer R LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Bone Miner Res JT - Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research JID - 8610640 RN - 0 (Ligands) RN - 0 (Receptors, Calcitriol) RN - 0 (Receptors, Retinoic Acid) RN - 0 (Recombinant Fusion Proteins) RN - 0 (Retinoid X Receptors) RN - 0 (Transcription Factors) RN - 1406-16-2 (Vitamin D) RN - 66772-14-3 (1,25-dihydroxyvitamin D) RN - 8DUH1N11BX (Tryptophan) RN - EC 2.3.1.48 (Histone Acetyltransferases) RN - EC 2.3.1.48 (NCOA1 protein, human) RN - EC 2.3.1.48 (Nuclear Receptor Coactivator 1) SB - IM MH - Amino Acid Substitution/genetics MH - Animals MH - Blotting, Western MH - COS Cells MH - Dimerization MH - Histone Acetyltransferases MH - Humans MH - Ligands MH - Mutation/genetics MH - Nuclear Receptor Coactivator 1 MH - Protein Binding MH - Receptors, Calcitriol/*chemistry/genetics/*metabolism MH - Receptors, Retinoic Acid/metabolism MH - Recombinant Fusion Proteins/chemistry/metabolism MH - Retinoid X Receptors MH - Transcription Factors/metabolism MH - *Transcriptional Activation/drug effects MH - Transfection MH - Tryptophan/genetics/*metabolism MH - Vitamin D/*analogs & derivatives/metabolism EDAT- 2001/01/10 11:00 MHDA- 2001/03/07 10:01 CRDT- 2001/01/10 11:00 PHST- 2001/01/10 11:00 [pubmed] PHST- 2001/03/07 10:01 [medline] PHST- 2001/01/10 11:00 [entrez] AID - 10.1359/jbmr.2001.16.1.39 [doi] PST - ppublish SO - J Bone Miner Res. 2001 Jan;16(1):39-45. doi: 10.1359/jbmr.2001.16.1.39.